MRC1 and neoplasm: Cases with homozygous pathogenic MMR gene alterations in the IHC control and screening group demonstrated a complete loss of expression in the tumor and surrounding brain tissue, while cases with heterozygous alterations showed retained MMR protein expression in the tumor vessels (Fig. 2a-d).